◆ Market Data --:--
Commodities
Loading...
📈 Yields & Rates
Loading...
💱 FX Rates
Loading...
📈 Market Pulse
Loading...
🏛 Congress Trades
Loading...
👤 Insider Trades
Loading...

NurExone Biologic Inc.

Financial Statements (IFRS) · Amounts in CAD
5 10 All
Income Statement
Balance Sheet
Cash Flow
Line Item FY 2024Dec 31, 2024 FY 2023Dec 31, 2023 FY 2022Dec 31, 2022 FY 2021Dec 31, 2021
Total Revenue 0.00 0.00 0.00 0.00
Operating Revenue 0.00 0.00 0.00 0.00
Selling General And Administration 3.1M 2.1M 4.1M 1.1M
General And Administrative Expense 3.1M 2.1M 4.1M 1.1M
Research And Development 1.9M 1.5M 1.4M 573,000
Depreciation And Amortization In Income Statement 30,000 21,000 14,000 0.00
Operating Expense 5.0M 3.7M 5.5M 1.7M
Operating Income -5.0M -3.7M -5.5M -1.7M
EBIT -5.0M -3.6M -8.1M -1.6M
Interest Expense 16,000 3,000 33,000 12,000
Interest Expense Non Operating 16,000 3,000 33,000 12,000
Net Interest Income 31,000 42,000 -18,000 -13,000
Other Income Expense -65,000 -24,000 -2.6M 79,000
Other Non Operating Income Expenses -42,000 -22,000 -66,000 -12,000
Special Income Charges -- 0.00 -2.1M 0.00
Restructuring And Mergern Acquisition -- 0.00 2.1M 0.00
Gain On Sale Of Security -23,000 -2,000 -466,000 79,000
Pretax Income -5.0M -3.6M -8.2M -1.6M
Tax Effect Of Unusual Items 0.00 0.00 0.00 0.00
Net Income From Continuing And Discontinued Operation -5.0M -3.6M -8.2M -1.6M
Net Income From Continuing Operation Net Minority Interest -5.0M -3.6M -8.2M -1.6M
Net Income Including Noncontrolling Interests -5.0M -3.6M -8.2M -1.6M
Net Income Common Stockholders -5.0M -3.6M -8.2M -1.6M
Net Income -5.0M -3.6M -8.2M -1.6M
EBITDA -4.9M -3.6M -8.1M -1.6M
Normalized EBITDA -4.9M -3.6M -5.6M -1.7M
Reconciled Depreciation 85,000 33,000 6,000 0.00
Basic EPS -0.08 -0.08 -0.22 -0.04
Diluted EPS -0.08 -0.08 -0.22 -0.04
Basic Average Shares 65.4M 44.7M 37.7M 42.4M
Diluted Average Shares 65.4M 44.7M 37.7M 42.4M
Total Unusual Items -23,000 -2,000 -2.5M 79,000
Total Unusual Items Excluding Goodwill -23,000 -2,000 -2.5M 79,000
Tax Rate For Calcs 0.00 0.00 0.00 0.00
Normalized Income -5.0M -3.6M -5.6M -1.7M
Amortization -- -- 14,000 0.00
Amortization Of Intangibles Income Statement -- -- 14,000 0.00
Depreciation Amortization Depletion Income Statement 30,000 21,000 14,000 0.00
Depreciation Income Statement 30,000 21,000 14,000 0.00
Diluted NI Availto Com Stockholders -5.0M -3.6M -8.2M -1.6M
Insurance And Claims 43,000 73,000 54,000 0.00
Net Income Continuous Operations -5.0M -3.6M -8.2M -1.6M
Net Non Operating Interest Income Expense 31,000 42,000 -18,000 -13,000
Other Gand A 1.7M 915,000 3.3M 791,000
Salaries And Wages 1.4M 1.1M 806,000 349,000
Total Expenses 5.0M 3.7M 5.5M 1.7M
Total Operating Income As Reported -5.0M -3.7M -7.6M -1.7M
Total Other Finance Cost -47,000 -45,000 -15,000 1,000
Line Item FY 2024Dec 31, 2024 FY 2023Dec 31, 2023 FY 2022Dec 31, 2022 FY 2021Dec 31, 2021
Cash And Cash Equivalents 700,000 541,000 2.5M 2.2M
Cash Cash Equivalents And Short Term Investments 700,000 541,000 2.5M 2.2M
Cash Equivalents 139,000 0.00 2.3M 0.00
Cash Financial 561,000 541,000 204,000 2.2M
Receivables 127,000 98,000 52,000 517,000
Prepaid Assets 766,000 114,000 123,000 86,000
Current Assets 1.6M 2.0M 2.7M 2.8M
Gross PPE 878,000 201,000 102,000 0.00
Accumulated Depreciation -71,000 -13,000 -1,000 0.00
Net PPE 807,000 188,000 101,000 0.00
Other Non Current Assets -- -- 1,000 --
Total Non Current Assets 807,000 188,000 102,000 0.00
Total Assets 2.4M 2.2M 2.8M 2.8M
Current Debt -- -- -- 1.0M
Current Debt And Capital Lease Obligation 2,000 18,000 24,000 1.0M
Payables 57,000 50,000 123,000 163,000
Payables And Accrued Expenses 396,000 598,000 579,000 346,000
Current Accrued Expenses 339,000 548,000 456,000 183,000
Current Deferred Revenue 0.00 95,000 0.00 --
Other Current Liabilities -- 1.2M -- 242,000
Current Liabilities 398,000 1.9M 603,000 1.6M
Long Term Debt And Capital Lease Obligation 31,000 2,000 20,000 0.00
Long Term Capital Lease Obligation 31,000 2,000 20,000 0.00
Other Non Current Liabilities -- -- 95,000 28,000
Total Non Current Liabilities Net Minority Interest 282,000 73,000 95,000 28,000
Total Liabilities Net Minority Interest 680,000 2.0M 698,000 1.7M
Common Stock 0.00 0.00 0.00 0.00
Capital Stock 0.00 0.00 0.00 0.00
Additional Paid In Capital 19.5M 13.3M 11.2M 3.3M
Retained Earnings -19.1M -14.1M -10.4M -2.2M
Gains Losses Not Affecting Retained Earnings -202,000 -45,000 -73,000 -5,000
Common Stock Equity 1.8M 189,000 2.1M 1.2M
Stockholders Equity 1.8M 189,000 2.1M 1.2M
Total Equity Gross Minority Interest 1.8M 189,000 2.1M 1.2M
Total Capitalization 1.8M 189,000 2.1M 1.2M
Net Tangible Assets 1.8M 189,000 2.1M 1.2M
Tangible Book Value 1.8M 189,000 2.1M 1.2M
Working Capital 1.2M 74,000 2.1M 1.2M
Invested Capital 1.8M 189,000 2.1M 2.2M
Total Debt 33,000 20,000 44,000 1.0M
Share Issued 71.1M 48.2M 42.9M 42.9M
Ordinary Shares Number 71.1M 48.2M 42.9M 42.9M
Capital Lease Obligations 33,000 20,000 44,000 0.00
Current Capital Lease Obligation 2,000 18,000 24,000 0.00
Current Deferred Liabilities 0.00 95,000 0.00 --
Current Notes Payable -- -- 0.00 1.0M
Duefrom Related Parties Current -- -- 0.00 451,000
Dueto Related Parties Current -- 0.00 22,000 0.00
Foreign Currency Translation Adjustments -202,000 -45,000 -73,000 -5,000
Leases 348,000 0.00 -- --
Machinery Furniture Equipment 493,000 201,000 102,000 0.00
Non Current Deferred Liabilities 173,000 0.00 -- --
Non Current Deferred Revenue 173,000 0.00 -- --
Other Equity Interest 1.6M 992,000 1.3M 174,000
Other Payable 57,000 50,000 101,000 163,000
Other Properties 37,000 -- -- --
Other Receivables 3,000 9,000 4,000 --
Properties 0.00 0.00 -- --
Restricted Cash 41,000 1.2M 54,000 19,000
Taxes Receivable 124,000 89,000 48,000 66,000
Tradeand Other Payables Non Current 78,000 71,000 75,000 28,000
Treasury Shares Number -- 0.00 -- --
Line Item FY 2024Dec 31, 2024 FY 2023Dec 31, 2023 FY 2022Dec 31, 2022 FY 2021Dec 31, 2021
Operating Cash Flow -4.9M -2.9M -3.8M -1.2M
Cash Flow From Continuing Operating Activities -4.9M -2.9M -3.8M -1.2M
Depreciation And Amortization 85,000 33,000 6,000 0.00
Depreciation Amortization Depletion 85,000 33,000 6,000 0.00
Stock Based Compensation 935,000 639,000 233,000 174,000
Change In Working Capital -923,000 4,000 237,000 289,000
Change In Receivables -88,000 -11,000 -10,000 -55,000
Change In Payables And Accrued Expense -102,000 47,000 -29,000 257,000
Change In Payable -102,000 47,000 -29,000 257,000
Change In Other Working Capital -133,000 -32,000 276,000 87,000
Other Non Cash Items 58,000 22,000 3.7M 12,000
Capital Expenditure -649,000 -120,000 -52,000 --
Purchase Of PPE -649,000 -120,000 -52,000 0.00
Net PPE Purchase And Sale -649,000 -120,000 -52,000 0.00
Investing Cash Flow -658,000 -97,000 -89,000 -19,000
Cash Flow From Continuing Investing Activities -658,000 -97,000 -89,000 -19,000
Issuance Of Debt -- 0.00 111,000 1.1M
Repayment Of Debt -30,000 -28,000 -15,000 0.00
Net Issuance Payments Of Debt -30,000 -28,000 96,000 1.1M
Issuance Of Capital Stock 2.7M 1.1M 2.3M 2.2M
Net Common Stock Issuance 2.7M 1.1M 2.3M 2.2M
Financing Cash Flow 5.9M 1.1M 4.3M 3.5M
Cash Flow From Continuing Financing Activities 5.9M 1.1M 4.3M 3.5M
Effect Of Exchange Rate Changes -173,000 -16,000 -109,000 0.00
Changes In Cash 332,000 -1.9M 358,000 2.2M
Beginning Cash Position 541,000 2.5M 2.2M 2,000
End Cash Position 700,000 541,000 2.5M 2.2M
Free Cash Flow -5.5M -3.1M -3.9M -1.2M
Change In Prepaid Assets -600,000 0.00 -- --
Common Stock Issuance 2.7M 1.1M 2.3M 2.2M
Depreciation 85,000 33,000 -- --
Gain Loss On Investment Securities -- -- 158,000 -60,000
Long Term Debt Payments -30,000 -28,000 -15,000 0.00
Net Income From Continuing Operations -5.0M -3.6M -8.2M -1.6M
Net Long Term Debt Issuance -30,000 -28,000 -15,000 0.00
Net Other Financing Charges 71,000 95,000 1.7M 118,000
Net Other Investing Changes -9,000 23,000 -37,000 -19,000
Net Short Term Debt Issuance -- 0.00 111,000 1.1M
Operating Gains Losses -- -- 158,000 -60,000
Proceeds From Stock Option Exercised 3.1M 0.00 148,000 0.00
Short Term Debt Issuance -- 0.00 111,000 1.1M
NEWS
Loading news...
TRENDING
Loading...